<DOC>
	<DOCNO>NCT00751166</DOCNO>
	<brief_summary>This randomize , double-blind , parallel-group , multicenter study use active control ( cetirizine ) placebo control evaluate desloratadine 5 mg daily 28-day treatment period . The active treatment placebo allocate 2:2:1 ratio .</brief_summary>
	<brief_title>A Comparative Double-blind , Double-dummy Study Desloratadine ( DL ) 5 mg Once Daily , Cetirizine 10 mg Once Daily , Placebo Once Daily Patients With Chronic Idiopathic Urticaria ( Study P03736 )</brief_title>
	<detailed_description />
	<mesh_term>Urticaria</mesh_term>
	<mesh_term>Desloratadine</mesh_term>
	<mesh_term>Loratadine</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<criteria>Have demonstrate willingness participate study comply procedure sign write informed consent . For pediatric patient , parent legal guardian sign write informed consent . Be 12 70 year age , either sex race . Have sign symptom CIU least 6 week prior Screening Visit . Have experience current flare CIU least 3 week prior Baseline Visit . Hives present least 3 day per week current flare prior Baseline Visit . Have overall condition CIU least `` moderate '' severity ( minimum score 2 ) Screening Baseline Visits . Have least moderately severe pruritus score ( minimum score 2 ) hive ( minimum score 1 ) present Screening . Have , Baseline , total pruritus score 14 great sum AM PM ( reflective ) diary score 3 day prior Baseline AM diary score Day 1 . Understand able adhere dose visit schedule , agree ass record symptom severity score , medication time , concomitant medication , adverse event accurately consistently daily diary . Be general good health free clinically significant disease ( CIU ) would interfere study evaluation . If female childbearing potential , negative urine ( hCG ) pregnancy test time Baseline ( Visit 2 ) . Female subject childbearing potential counseled appropriate use birth control study . They use medically accept method birth control , example : double barrier method , oral contraceptive , DepoProvera® , Norplant® , prior Baseline study . Women sexually active agree consent use one abovementioned method become sexually active participate study . If subject tubal ligation use intrauterine device , husband/partner vasectomy , another method use . Had asthma require chronic use inhale systemic corticosteroid . Had unresponsive antihistamine treatment past . Had history allergy two class medication allergic unable tolerate antihistamine . Had use investigational drug last 30 day prior Baseline . Had food drug allergy manifest skin reaction . Subjects urticaria primarily due physical urticaria know etiology . If female , pregnant nursing . Had history hypersensitivity study drug excipients . Were family member investigational study staff involve study . Had previously randomize study . Had current evidence clinically significant hematopoietic , cardi distribution , metabolism , excretion study medication subject 's ability reliably complete diary card . Were morbidly obese ( BMI &gt; = 35 , describe Appendix 6 protocol ) Had compromise ability provide inform consent . Had history noncompliance medication treatment protocol .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>